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Figure 2. MicroCT and Histology Findings in the LM and LCX
(A) MicroCT 3-dimensional reconstruction of the left main (LM) and left circumﬂex (LCX) coronary artery stents with a magniﬁed image of the fractured segment
to the right. The red dots highlight fracture points, with the dotted lines indicating the original connection. The calciﬁed plaque is colored yellow, and residual
intraluminal contrast is red. (B) Corresponding histological cross sections of LM/LCX stents demonstrating focal restenosis at the area of fracture. LAD  left
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Figure 3. MicroCT and Histology Findings in the RCA
(A) Micro-computed tomography (microCT) 3-dimensional reconstruction of the right coronary artery (RCA) stent with a magniﬁed image of the fractured seg-
ment to the right. The red dots highlight fracture points, with the dotted line indicating the original connection. The calciﬁed plaque is colored yellow, and
residual intraluminal contrast is red. (B) Corresponding histological cross sections of the RCA stent demonstrating focal restenosis at the area of fracture, with
inﬂammation and ﬁbrin accumulation at areas of polymer displacement.
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241ing of the left main coronary artery into the LCX with a
3.5  18-mm Xience V stent (Abbott Vascular, Santa Clara,
California). A second 3.5  18-mm Xience V stent was
overlapped distally to cover a mid LCX lesion, and both
stents were post-dilated to 16 atm with a 3.5-mm noncom-
pliant balloon. The RCA lesion was stented with a 3.0 
12-mm Xience V and post-dilated to 16 atm with a 3.0-mm
noncompliant balloon (Fig. 1). The patient did well for 6
months until she returned with unstable angina. Angiogra-
phy revealed restenosis at the ostium of the stented LCX
and within the distal RCA stent (Fig. 1). During repeat
intervention, wiring of the LCX resulted in abrupt closure. The
patient developed refractory ventricular fibrillation and died.
A post-mortem examination was performed in which the
coronary arteries were pressure flushed, formalin fixed,
perfused with a lead-based contrast agent (Microfil MV-
120, FlowTech, Carver, Massachusetts), and the stented
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Figure 4. Fracture Site Histology
(A) Histological cross sections at the LCX stent fracture site demonstrating hea
hyperplasia (Movat stain, original magniﬁcation: 12.5). (B) RCA stent fracture
eosin stain, original magniﬁcation: 20). The right image is a higher magniﬁc
mation (original magniﬁcation: 200). Abbreviations as in Figure 1.segments were resected under fluoroscopic guidance. Theexplanted arterial segments were then scanned using a GE
eXplore SP MicroCT scanner (GE Healthcare, London, On-
tario, Canada) (1). Three-dimensional reconstructions at
3-m resolution demonstrated heavy calcification and
stent fracture at the sites of maximal restenosis. Both Xience
V stents fractured in the middle of the hairpin bend in the
connecting element and along the crown at the base of the
connecting element. Histology of both stents revealed
underlying heavy fibrocalcific plaque and extensive neointi-
mal hyperplasia at the fracture site without thrombus
(Figs. 2 and 3). The histology of the RCA stent demon-
strates inflammation and fibrin accumulation, possibly re-
lated to sloughed polymer at the site of fracture (Fig. 4).
Autopsy studies have suggested a correlation between severe
first-generation stent fracture and restenosis (2). In this case
of clinical everolimus drug-eluting stent restenosis at 6
months, it is unclear whether stent fracture induced reste-
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242calcium, tortuosity, torsion, and local plaque composition
lead to restenosis with coincidental stent fracture.
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